Search

Author/Creator Watanabe-Fujinuma, Emi

1. Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: The case study of Japan. (1st September 2016)

Authors:
Hori, Masatsugu; Ikeda, Shunya; Okumura, Ken; Matsuda, Shinya; Koretsune, Yukihiro; Montouchet, Calypso; Watanabe-Fujinuma, Emi; Evers, Thomas; Rossi, Bruno; Ruff, Lewis; Briere, Jean-Baptiste
Journal:
Journal of medical economics
Issue:
Volume 19:Number 9(2016)
Page Start:
889
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study. (2nd December 2018)

Authors:
Koretsune, Yukihiro; Kumagai, Koichiro; Uchiyama, Shinichiro; Yamashita, Takeshi; Yasaka, Masahiro; Watanabe-Fujinuma, Emi; Banderas, Benjamin F.; Akiyama, Sayako; Okayama, Yutaka; Briere, Jean-Baptiste; Dickie, Gavin; Cano, Stefan J.
Journal:
Current medical research and opinion
Issue:
Volume 34:Number 12(2018)
Page Start:
2157
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Psychometric validation of anti-clot treatment scale and treatment satisfaction questionnaire for medication version II in Japanese patients with atrial fibrillation. (3rd August 2019)

Authors:
Watanabe-Fujinuma, Emi; Banderas, Benjamin F.; Koretsune, Yukihiro; Kumagai, Koichiro; Uchiyama, Shinichiro; Yamashita, Takeshi; Yasaka, Masahiro; Akiyama, Sayako; Briere, Jean-Baptiste; Dickie, Gavin; Cano, Stefan J.
Journal:
Journal of medical economics
Issue:
Volume 22:Number 8(2019)
Page Start:
798
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗